![](/img/cover-not-exists.png)
FOLFOXIRIâBevacizumab or FOLFOXâPanitumumab in Patients with LeftâSided RAS / BRAF WildâType Metastatic Colorectal Cancer: A Propensity ScoreâBased Analysis
Pietrantonio, Filippo, Fucà , Giovanni, Rossini, Daniele, Schmoll, HansâJoachim, Bendell, Johanna C., Morano, Federica, Antoniotti, Carlotta, Corallo, Salvatore, Borelli, Beatrice, Raimondi, AlessanJournal:
The Oncologist
DOI:
10.1002/onco.13642
Date:
January, 2021
File:
PDF, 984 KB
2021